Genetic approaches to unraveling reproductive disorders: Examples of bedside to bench research in the genomic era

Endocrine Reviews

Volumn 23, Issue 3, 2002, Pages 382-392

  Seminara, Stephanie B ^a,b   Crowley Jr , William F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Endocrine Unit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; DAX-1 PROTEIN; DNA BINDING PROTEIN; NUCLEAR RECEPTOR DAX 1; REPRESSOR PROTEIN; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR;

ADRENAL INSUFFICIENCY; CONGENITAL ADRENAL HYPOPLASIA; DNA POLYMORPHISM; GENE MAPPING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HORMONAL REGULATION; HUMAN; HYPERGONADOTROPIC OVARIAN FAILURE; LINKAGE ANALYSIS; NONHUMAN; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VARIABLE NUMBER OF TANDEM REPEAT; FEMALE; GENETIC LINKAGE; GENETIC PROCEDURES; GENETICS; GENOMICS; INFERTILITY; PHENOTYPE; PREMATURE OVARIAN FAILURE; RESEARCH;

DNA-BINDING PROTEINS; FEMALE; GENETIC TECHNIQUES; GENOMICS; HUMANS; INFERTILITY; LINKAGE (GENETICS); OVARIAN FAILURE, PREMATURE; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; RESEARCH; TRANSCRIPTION FACTORS;

EID: 85047686166     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.23.3.0469     Document Type: Review

References (109)

1. Zur kenntnis der antifermentativen, lytischen und agglutinierended wikungen des blutserums und der lymphe
2. DNA sequence variants in the Gγ-, Aγ-, δ-, and β-globin genes of man
3. Hypervariable 'minisatellite' regions in human DNA
4. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction
5. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome
6. An SNP map of human chromosome 22
7. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
8. DNA methylation and mutation
9. High density synthetic oligonucleotide arrays
10. The generalized sib pair IBD distribution: Its use in the detection of linkage
11. Association study designs for complex diseases
12. Linkage analysis of "necessary" disease loci versus "susceptibility" loci
13. Association studies of genetic polymorphisms and complex disease
14. Use of siblings in case-control association studies
15. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
16. Genetic association mapping at the crossroads: Which test and why? Overview and practical guidelines
17. Genetically determined sex-reversal in 46,XY humans
18. Probable inverted tandem duplication of Xp in a 46,Xp+Y boy
19. Female phenotype and multiple abnormalities in sibs with a Y chromosome and partial X chromosome duplication: H-Y antigen and Xg blood group findings
20. Duplication of an Xp segment that includes the ZFX locus causes sex inversion in man
21. Sex reversal in a child with a 46,X, Yp + karyotype: Support for the existence of a gene(s), located in distal Xp, involved in testis formation
22. Report of a kindred with X-linked (or autosomal dominant sex-limited) 46,XY partial gonadal dysgenesis
23. Functional disomy of Xp22-pter in three males carrying a portion of Xp translocated to Yq
24. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal
25. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita
26. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism
27. Diagnosis of X-linked adrenal hypoplasia congenita by mutation analysis of the DAX 1 gene
28. Truncation at the C-terminus of the DAX-1 protein impairs its biological actions in patients with X-linked adrenal hypoplasia congenita
29. DAX1 mutations map to putative structural domains in a deduced three-dimensional model
30. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita
31. DAX1 antagonizes Sry action in mammalian sex determination
32. Expression of DAX-1, the gene responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, in the hypothalamic-pituitary-adrenal/gonadal axis
33. Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: Potential links in endocrine development
34. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis
35. A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita
36. DAX-1 inhibits SF-1 mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita
37. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1
38. Active hypothalamic-pituitary-gonadal axis in an infant with X-linked adrenal hypoplasia congenita
39. Congenital adrenal hypoplasia: Clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene
40. X-linked adrenal hypoplasia congenita: A mutation in DAX1 expands the phenotypic spectrum in males and females
41. Novel DAX1 mutations in X-linked adrenal hypoplasia congenita and hypogonadotrophic hypogonadism
42. Hypogonadism in congenital adrenal hypoplasia: Evidence for a hypothalamic origin
43. Contrasting effects of subcutaneous pulsatile GnRH therapy in congenital adrenal hypoplasia and Kallmann's syndrome
44. Failure to induce puberty in a man with X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism by pulsatile administration of low-dose gonadotropin-releasing hormone
45. Lack of gonadotropic response to pulsatile gonadotropin-releasing hormone in isolated hypogonadotropic hypogonadism associated to congenital adrenal hypoplasia
46. Hypothalamic hypogonadism in congenital adrenal hypoplasia
47. X-linked adrenal hypoplasia in a large Greenlandic family. Detection of a missense mutation (N440I) in the DAX-1 gene; implication for genetic counseling and carrier diagnosis
48. A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism
49. Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita
50. Role of Ahch in gonadal development and gametogenesis
51. Sertoli cell specific rescue of fertility, but not testicular pathology, in Dax1 (Ahch)-deficient male mice
52. Blockage of the rete testis and efferent ductules by ectopic Sertoli and Leydig cells causes infertility in Dax1-deficient male mice
53. Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene
54. Vulnerability within a robust complex system-DAX-1 mutations and steroidogenic axis development
55. No evidence of the inactivating mutation (C566T) in the follicle-stimulating hormone receptor gene in Brazilian women with premature ovarian failure
56. The follicle stimulating hormone receptor gene is polymorphic in premature ovarian failure and normal controls
57. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome
58. Identification of allelic variants in the follicle-stimulating hormone receptor genes of females with or without hypergonadotropic amenorrhea
59. Screening male intracytoplasmic sperm injection candidates for mutations of the follicle stimulating hormone receptor gene
60. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: Identification and characterization of two discrete FSH receptor isoforms
61. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure
62. Gonadal dysgenesis in individuals with apparently normal chromosomal complements: Tabulation of cases and compilation of genetic data
63. The genetics of gonadal dysgenesis
64. Localization of the human LH (luteinizing hormone) receptor gene to chromosome 2p21
65. The chromosomal localization of the human follicle-stimulating hormone receptor gene (FSHR) on 2p21-2p16 is similar to that of the luteinizing hormone receptor gene
66. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty
67. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty
68. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty
69. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene
70. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene
71. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility
72. Hormonal control of mammalian spermatogenesis
73. Is FSH required for adult spermatogenesis?
74. Follicle-stimulating hormone and human spermatogenesis
75. A prospective study of the prevalence of clear cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism of androgenic alopecia
76. Polycystic ovaries-a common finding in normal women
77. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?
78. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease
79. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
80. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
81. Banting lecture 1988. Role of insulin resistance in human disease
82. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents
83. Defects in β-cell function in functional ovarian hyperandrogenism
84. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus
85. β-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome
86. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
87. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
88. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
89. Hereditary factors in Stein-Leventhal syndrome
90. The inheritance of polycystic ovarian disease and a possible relationship to premature balding
91. Familial clustering in the polycystic ovarian syndrome
92. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness
93. Familial polycystic ovaries: A genetic disease?
94. Familial polycystic ovarian disease
95. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17
96. 5′ Polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries
97. Frequency of a polymorphism in the regulatory region of the 17α-hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic states
98. The 17α-hydroxylase/17,20 lyase gene (CYP17) and polycystic ovary syndrome
99. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism
100. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome
101. Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5′ flanking region of the human insulin gene
102. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus
103. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome
104. Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin
105. The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome
106. Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome
107. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome
108. Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus
109. Allelic variants of the follistatin gene in polycystic ovary syndrome